Rhythm Pharmaceuticals (RYTM) Receivables (2021 - 2025)
Historic Receivables for Rhythm Pharmaceuticals (RYTM) over the last 5 years, with Q3 2025 value amounting to $33.0 million.
- Rhythm Pharmaceuticals' Receivables rose 7110.74% to $33.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $33.0 million, marking a year-over-year increase of 7110.74%. This contributed to the annual value of $18.5 million for FY2024, which is 2451.74% up from last year.
- Per Rhythm Pharmaceuticals' latest filing, its Receivables stood at $33.0 million for Q3 2025, which was up 7110.74% from $26.1 million recorded in Q2 2025.
- In the past 5 years, Rhythm Pharmaceuticals' Receivables registered a high of $33.0 million during Q3 2025, and its lowest value of $862000.0 during Q1 2022.
- In the last 5 years, Rhythm Pharmaceuticals' Receivables had a median value of $14.6 million in 2023 and averaged $13.2 million.
- As far as peak fluctuations go, Rhythm Pharmaceuticals' Receivables surged by 84164.73% in 2023, and later skyrocketed by 2129.98% in 2025.
- Over the past 5 years, Rhythm Pharmaceuticals' Receivables (Quarter) stood at $1.0 million in 2021, then skyrocketed by 507.22% to $6.2 million in 2022, then soared by 138.87% to $14.9 million in 2023, then increased by 24.52% to $18.5 million in 2024, then skyrocketed by 78.45% to $33.0 million in 2025.
- Its Receivables stands at $33.0 million for Q3 2025, versus $26.1 million for Q2 2025 and $17.8 million for Q1 2025.